Discovering YOU Magazine May 2018 Issue - Page 16

HEALTH MATTERS

affected cancer cells to die. The therapy, which you can learn more about on Novocure.com, received its first approval by the FDA for a specific type of aggressive brain cancer in 2011.

Clinical research on Tumor Treating Fields has continued, and the treatment shows promise in multiple solid tumor types - including some of the most aggressive forms of cancer. The therapy has been shown to have minimal side effects, with mild to moderate skin irritation being the most common side effect. Bioelectronic treatments not only have the benefit of typically causing fewer side effects, but there is also room to improve the treatment through engineering.

"One of the benefits of having a device over a drug is we can continue to develop and improve the technology over time," explained Eilon Kirson, Chief Science Officer and Head of Research and Development at Novocure. "We're not locked into a chemical formula. The platform can continue to evolve."

The field of bioelectronic medicine itself continues to progress, having only come into being in the late 20th century. With so much advancement made in such a short time, the promise of what may come in the future feels pulled straight from the big screen.

"One of the benefits of having a device over a drug is we can continue to develop and improve

the technology

over time," ....